Greenway, Frank L.

A Randomized, Controlled Trial of 3.0 mg of Liraglutide in Weight Management

Pi-Sunyer, X., Astrup, A., Fujioka, K., Greenway, F., Halpern, A., Krempf, M., Lau, D. C. W., le Roux, C. W., Violante Ortiz, R., Jensen, C. B., et al. (2015) · New England Journal of Medicine

Pharmacology and Obesity TreatmentDiabetes Treatment and Management

Cited by 2,724

Comparison of Weight-Loss Diets with Different Compositions of Fat, Protein, and Carbohydrates

Sacks, F. M., Bray, G. A., Carey, V. J., Smith, S. R., Ryan, D. H., Anton, S. D., McManus, K., Champagne, C. M., Bishop, L. M., Laranjo, N., et al. (2009) · New England Journal of Medicine

Diet and metabolism studiesDietary Effects on Health

Cited by 1,966

Effect of naltrexone plus bupropion on weight loss in overweight and obese adults (COR-I): A multicentre, randomised, double-blind, placebo-controlled, phase 3 trial

Greenway, F. L., Fujioka, K., Plodkowski, R. A., Mudaliar, S., Guttadauria, M., Erickson, J., Kim, D. D., & Dunayevich, E. (2010) · The Lancet

Pharmacology and Obesity TreatmentRegulation of Appetite and Obesity

Cited by 1,036

Effect of 6-Month Calorie Restriction on Biomarkers of Longevity, Metabolic Adaptation, and Oxidative Stress in Overweight Individuals: A Randomized Controlled Trial

Heilbronn, L. K., de Jonge, L., Frisard, M. I., DeLany, J. P., Larson-Meyer, D. E., Rood, J., Nguyen, T., Martin, C. K., Volaufova, J., Most, M. M., et al. (2006) · JAMA

Dietary Effects on HealthGenetics, Aging, and Longevity in Model Organisms

Cited by 969

Endocrine and Nutritional Management of the Post-Bariatric Surgery Patient: An Endocrine Society Clinical Practice Guideline

Heber, D., Greenway, F. L., Kaplan, L. M., Livingston, E., Salvador, J., & Still, C. (2010) · The Journal of Clinical Endocrinology & Metabolism

Bariatric Surgery and OutcomesMinimally Invasive Surgical Techniques

Cited by 521

Effects of naltrexone sustained-release/bupropion sustained-release combination therapy on body weight and glycemic parameters in overweight and obese patients with type 2 diabetes

Hollander, P., Gupta, A. K., Plodkowski, R., Greenway, F., Bays, H., Burns, C., Klassen, P., Fujioka, K., & for the COR-Diabetes Study Group (2013) · Diabetes Care

Pharmacology and Obesity TreatmentDiabetes Treatment and Management

Cited by 501

Physiological adaptations to weight loss and factors favouring weight regain

Greenway, F. L. (2015) · International Journal of Obesity

Regulation of Appetite and ObesityPharmacology and Obesity Treatment

Cited by 431

A healthy gastrointestinal microbiome is dependent on dietary diversity

Heiman, M. L., & Greenway, F. L. (2016) · Molecular Metabolism

Gut microbiota and healthNutritional Studies and Diet

Cited by 370

Bupropion SR Enhances Weight Loss: A 48‐Week Double‐Blind, Placebo‐ Controlled Trial

Anderson, J. W., Greenway, F. L., Fujioka, K., Gadde, K. M., McKenney, J., & O'Neil, P. M. (2002) · Obesity Research

Pharmacology and Obesity TreatmentEating Disorders and Behaviors

Cited by 315

Caloric restriction alone and with exercise improves CVD risk in healthy non-obese individuals

Lefevre, M., Redman, L. M., Heilbronn, L. K., Smith, J. V., Martin, C. K., Rood, J. C., Greenway, F. L., Williamson, D. A., Smith, S. R., & Ravussin, E. (2009) · Atherosclerosis

Dietary Effects on HealthCardiovascular and exercise physiology

Cited by 217

Dietary fiber and satiety: the effects of oats on satiety

Rebello, C. J., O’Neil, C. E., & Greenway, F. L. (2016) · Nutrition Reviews

Food composition and propertiesRegulation of Appetite and Obesity

Cited by 188

Comparison of Combined Bupropion and Naltrexone Therapy for Obesity with Monotherapy and Placebo

Greenway, F. L., Dunayevich, E., Tollefson, G., Erickson, J., Guttadauria, M., Fujioka, K., Cowley, M. A., & for the NB-201 Study Group (2009) · The Journal of Clinical Endocrinology & Metabolism

Pharmacology and Obesity TreatmentRegulation of Appetite and Obesity

Cited by 179

A randomized, double-blind, placebo-controlled study of gelesis100: A novel nonsystemic oral hydrogel for weight loss

Greenway, F. L., Aronne, L. J., Raben, A., Astrup, A., Apovian, C. M., Hill, J. O., Kaplan, L. M., Fujioka, K., Matejkova, E., Svacina, S., et al. (2019) · Obesity

Pharmacology and Obesity TreatmentBariatric Surgery and Outcomes

Cited by 179

Comparison of Methods to Assess Body Composition Changes during a Period of Weight Loss

Frisard, M. I., Greenway, F. L., & DeLany, J. P. (2005) · Obesity Research

Body Composition Measurement TechniquesObesity, Physical Activity, Diet

Cited by 153

Centrally Acting Agents for Obesity: Past, Present, and Future

Coulter, A. A., Rebello, C. J., & Greenway, F. L. (2018) · Drugs

Pharmacology and Obesity TreatmentRegulation of Appetite and Obesity

Cited by 151

Psychosocial variables associated with binge eating in obese males and females

Womble, L. G., Williamson, D. A., Martin, C. K., Zucker, N. L., Thaw, J. M., Netemeyer, R., Lovejoy, J. C., & Greenway, F. L. (2001) · International Journal of Eating Disorders

Eating Disorders and BehaviorsNutrition, Health and Food Behavior

Cited by 137

Early weight loss with liraglutide 3.0 mg predicts 1-year weight loss and is associated with improvements in clinical markers

Fujioka, K., O'Neil, P. M., Davies, M., Greenway, F., C.W. Lau, D., Claudius, B., Skjøth, T. V., Bjørn Jensen, C., & P.H. Wilding, J. (2016) · Obesity

Pharmacology and Obesity TreatmentDiabetes Treatment and Management

Cited by 131

Long-term effects of metformin on diabetes prevention: identification of subgroups that benefited most in the Diabetes Prevention Program and Diabetes Prevention Program Outcomes Study

Diabetes Prevention Program Research Group, Nathan, D. M., Knowler, W. C., Edelstein, S., Crandall, J. P., Dabelea, D., Goldberg, R. B., Kahn, S. E., Mather, K. J., Trandafirescu, G., et al. (2019) · Diabetes Care

Diabetes Treatment and ManagementDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 128

Weight loss and improved quality of life with a nonsurgical endoscopic treatment for obesity: clinical results from a 3- and 6-month study

Marinos, G., Eliades, C., Raman Muthusamy, V., & Greenway, F. (2014) · Surgery for Obesity and Related Diseases

Bariatric Surgery and OutcomesMinimally Invasive Surgical Techniques

Cited by 123

Retention rates and weight loss in a commercial weight loss program

Finley, C. E., Barlow, C. E., Greenway, F. L., Rock, C. L., Rolls, B. J., & Blair, S. N. (2007) · International Journal of Obesity

Obesity, Physical Activity, DietPharmacology and Obesity Treatment

Cited by 117

The Effect of Intentional Weight Loss on Fracture Risk in Persons With Diabetes: Results From the Look AHEAD Randomized Clinical Trial

Johnson, K. C., Bray, G. A., Cheskin, L. J., Clark, J. M., Egan, C. M., Foreyt, J. P., Garcia, K. R., Glasser, S., Greenway, F. L., Gregg, E. W., et al. (2017) · Journal of Bone and Mineral Research

Bone health and osteoporosis researchDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 104

How Physician Obesity Specialists Use Drugs to Treat Obesity

Hendricks, E. J., Rothman, R. B., & Greenway, F. L. (2009) · Obesity

Pharmacology and Obesity TreatmentBariatric Surgery and Outcomes

Cited by 97

Blood pressure and heart rate effects, weight loss and maintenance during long-term phentermine pharmacotherapy for obesity

Hendricks, E. J., Greenway, F. L., Westman, E. C., & Gupta, A. K. (2011) · Obesity

Pharmacology and Obesity TreatmentBlood Pressure and Hypertension Studies

Cited by 97

Self-help weight loss versus a structured commercial program after 26 weeks: a randomized controlled study

Heshka, S., Greenway, F., Anderson, J. W., Atkinson, R. L., Hill, J. O., Phinney, S. D., Miller-Kovach, K., & Xavier Pi-Sunyer, F. (2000) · The American Journal of Medicine

Obesity, Physical Activity, DietPharmacology and Obesity Treatment

Cited by 83